Navigation Links
Scientific Presentations at 2011 AAPM/COMP Meeting Highlight TrueBeam® and RapidArc® Radiotherapy Systems From Varian Medical Systems
Date:8/9/2011

VANCOUVER, British Columbia, Aug. 9, 2011 /PRNewswire/ -- Medical physicists researching RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR) have reported that, compared with conventional approaches to radiotherapy, RapidArc treatment plans for lung, abdominal and spinal tumors do a better job of sparing healthy tissues and organs.

Presenting at a professional conference of medical physicists last week, a team from Mount Sinai Medical Center in New York reported that a RapidArc treatment plan for treating a single complex case of lung cancer spared more healthy tissues and critical organs than a treatment plan for IMRT or 3-D conformal radiotherapy.  In this treatment plan comparison study, the average dose to healthy lung tissues was 8 Gy lower for the RapidArc plan as compared with the other two treatment approaches. The amount of healthy tissue receiving 10-20% of the prescribed dose—a common way of measuring how much healthy tissue is being impacted—was 45% to 50% lower for the RapidArc plan, compared to the other two plan types.  In addition, the investigators found the RapidArc plan offered better tumor coverage than the 3-D conformal radiotherapy plan.(1)

"RapidArc for whole abdominal irradiation in patients offers better homogeneity with the same level of kidney sparing while providing more sparing of organs at risk, such as the bone marrow," concluded a team of researchers from North Shore Long Island Jewish Health System, in a poster presentation comparing RapidArc with a more conventional 2-beam approach to whole abdominal radiotherapy for a single patient.  For example, the amount of healthy bone marrow receiving up to 90% of the prescribed dose went from 95.13% with the conventional treatment plan down to 18.4% in the RapidArc plan.(2) Whole abdominal radiotherapy is often prescribed for some gynecologi
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
10. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
11. Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... TORONTO , Jan. 15, 2014  According to ... medical technology market intelligence, the United ... occlusion (TEO) device markets will expand moderately through ... fastest-growing segments. In particular, increasing interest in drug-eluting ...
(Date:1/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") ... its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for ... Solta Medical, Inc. (NASDAQ: SLTM ) ("Solta") ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
(Date:7/9/2014)... feelings are personal and subjective, the human brain ... represents emotions across different senses, situations and even ... neuroscientist Adam Anderson. , "We discovered that fine-grained ... an area of the brain associated with emotional ... an individual,s subjective feeling," says Anderson, associate professor ...
(Date:7/9/2014)... There has been a sharp increase in the ... using MyChart, the online, interactive service that allows patients ... healthcare providers, schedule appointments, and renew prescriptions. , Over ... MyChart each year increased five-fold, while the ... 10-fold, according to a study by Dr. David ...
(Date:7/9/2014)... declines and extinctions around the world have been ... but new research from the National Institute for ... pathogen, ranavirus, may also contribute. , In ... ranavirus, which causes severe hemorrhage of internal organs ... of wood frogs if they are exposed to ...
(Date:7/9/2014)... flatulence and have a reputation for being highly toxic, but ... now being being found to offer potential health benefits in ... and dementia. A new compound (AP39), designed and made at ... therapies, by targeting delivery of very small amounts of the ... , Scientists in Exeter have already found that the compound ...
(Date:7/9/2014)... the most important organs in the human body. Its ... properly this is its synthesis function and ... this is its detoxification function. Lack of exercise and ... the liver. The resulting diseased cells can lead to ... failure. According to the German Liver Foundation, over five ...
Breaking Medicine News(10 mins):Health News:Study cracks how the brain processes emotions 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3
... designs a telemedicine system using interactive digital television. ... of Navarre, Alejandro Fanjul Fernández, has designed a ... This system enables the monitoring and treatment of ... from the comfort and convenience of their homes, ...
... a novel pathway by which estradiol, the primary estrogen ... as it aids in avoiding osteoporosis. // ,It ... bone, and that when the production of estrogen is ... after exposure to radiation or chemotherapeutic drugs, bones become ...
... day give their children a weekly treatment with a nasal ... severe middle //ear infection, based on results of a study. ... use of antibiotics, thereby avoiding the problem of antibiotic resistance. ... is an inflammation of the middle ear space that can ...
... Wisconsin is running a pioneering trial of using stem ... which have //been "encouraging". ,Amish Raval, of ... cardiologists began their trial on March 7. ... it could revolutionize cardiology," said Raval. ,Stem ...
... registered in the US National Marrow Donor Registry// is so ... queue for matching donors. ,Urmi and Girish are ... here. ,Urmi, 5, has been diagnosed with aplastic ... play with her dolls and read stories about Lord Krishna ...
... University College of Dentistry has discovered the first conclusive proof ... human hosts. This can even be ... between 100,000 and 200,000 years ago, say the researchers. ... cariology and comprehensive care at NYUCD, discovered that Streptococcus mutans, ...
Cached Medicine News:Health News:Interactive Digital Television to Monitor Health 2Health News:Interactive Digital Television to Monitor Health 3Health News:Estradiol Guards Against Osteoporosis 2Health News:Viral Enzyme Recruited in Fight Against Ear Infection 2Health News:Viral Enzyme Recruited in Fight Against Ear Infection 3Health News:Tooth Decay Bacteria Evolved Along With Man 2
Joseph skin hook is a single end-sharp with 2 prong....
Experience great vision, comfort and durability in a quarterly-replacement lens....
A unique lens system featuring Balanced Progressive Technology for optimum vision quality at every distance....
The proven daily wear spherical soft contact lens....
Medicine Products: